These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 927252)

  • 1. Effect of dose on antibody response to subunit influenza vaccine.
    Feery BJ; Hampson AW; Forsyth JR; Evered MG
    Med J Aust; 1977 Sep; 2(10):324-7. PubMed ID: 927252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous and heterologous antibody responses to subunit influenza virus vaccine.
    Feery BJ; Evered MG; Hayes K
    J Hyg (Lond); 1978 Dec; 81(3):331-6. PubMed ID: 581591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to one and two doses of influenza virus subunit vaccine.
    Feery BJ; Cheyne IM; Hampson AW; Atkinson MI
    Med J Aust; 1976 Feb; 1(7):186, 188-9. PubMed ID: 1272148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to influenza vaccines containing A/USSR/90/77.
    Feery BJ; Gallichio HA; Rodda SJ; Hampson AW
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):335-44. PubMed ID: 394734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
    Nicholson KG; Colegate AE; Podda A; Stephenson I; Wood J; Ypma E; Zambon MC
    Lancet; 2001 Jun; 357(9272):1937-43. PubMed ID: 11425416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.
    Stephenson I; Nicholson KG; Glück R; Mischler R; Newman RW; Palache AM; Verlander NQ; Warburton F; Wood JM; Zambon MC
    Lancet; 2003 Dec; 362(9400):1959-66. PubMed ID: 14683655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM; Camilloni B; Basileo M; Neri M; Lepri E; Spighi M
    Gerontology; 2007; 53(6):411-8. PubMed ID: 17975317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-scale trial of live-attenuated influenza vaccine (A/Hong Kong/68).
    West R; Stewart JA; White FM; McDonald JC; Boudreault A; Pavilanis V
    Can J Microbiol; 1977 Mar; 23(3):253-7. PubMed ID: 322827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Influenza virus subunit vaccine: a case for two doses.
    Mackenzie JS
    Med J Aust; 1976 Apr; 1(15):546-7. PubMed ID: 933947
    [No Abstract]   [Full Text] [Related]  

  • 15. Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components.
    Beyer WE; Versluis DJ; Kramer P; Diderich PP; Weimar W; Masurel N
    Vaccine; 1987 Mar; 5(1):43-8. PubMed ID: 3577356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to influenza vaccines containing A/New Jersey/8/76.
    Feery BJ; Hampson AW; Rodda SJ; Evered MG
    Aust J Exp Biol Med Sci; 1978 Dec; 56(6):639-47. PubMed ID: 752306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year evaluation of four commercial equine influenza vaccines in ponies maintained in isolation.
    Burrows R; Spooner PR; Goodridge D
    Dev Biol Stand; 1977 Jun 1-3; 39():341-6. PubMed ID: 604118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Influenza virus subunit vaccine.
    Feery BJ
    Med J Aust; 1976 Apr; 1(16):592-3. PubMed ID: 933961
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.